The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches
Open accessAbstract
Advances in multimodal immunotherapy have significantly reduced acute rejection rates and substantially improved 1-year graft survival following renal transplantation. However, long-term (10-year) survival rates have stagnated over the past decade. Recent studies indicate that antibody-mediated rejection (ABMR) is among the most important barriers to improving long-term outcomes. Improved understanding of the roles of acute and chronic ABMR has evolved in recent years following major progress in the technical ability to detect and quantify recipient anti-HLA antibody production. Additionally, new knowledge of the immunobiology of B cells and plasma cells that pertains to allograft rejection and tolerance has emerged. Still, questions regarding the classification of ABMR, the precision of diagnostic approaches, and the efficacy of various strategies for managing affected patients abound. This review article provides an overview of current thinking and research surrounding the pathophysiology and diagnosis of ABMR, ABMR-related outcomes, ABMR prevention and treatment, as well as possible future directions in treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
Hariharan, S., Johnson, C. P., Bresnahan, B. A., Taranto, S. E., McIntosh, M. J., & Stablein, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003023420901 · Cited by 1,835
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
Kasiske, B. L., Zeier, M. G., Chapman, J. R., Craig, J. C., Ekberg, H., Garvey, C. A., Green, M. D., Jha, V., Josephson, M. A., Kiberd, B. A., et al. (2010) · Kidney International · doi:10.1038/ki.2009.377 · Cited by 1,735
Sellarés, J., de Freitas, D. G., Mengel, M., Reeve, J., Einecke, G., Sis, B., Hidalgo, L. G., Famulski, K., Matas, A., & Halloran, P. F. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03840.x · Cited by 1,590
Self-citationImmunosuppressive Drugs for Kidney Transplantation
Halloran, P. F. (2004) · New England Journal of Medicine · doi:10.1056/nejmra033540 · Cited by 1,555
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Haas, M., Sis, B., Racusen, L. C., Solez, K., Glotz, D., Colvin, R. B., Castro, M. C. R., David, D. S. R., David-Neto, E., Bagnasco, S. M., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12590 · Cited by 1,350
Meier-Kriesche, H.-U., Schold, J. D., Srinivas, T. R., & Kaplan, B. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00332.x · Cited by 1,287
Wiebe, C., Gibson, I. W., Blydt-Hansen, T. D., Karpinski, M., Ho, J., Storsley, L. J., Goldberg, A., Birk, P. E., Rush, D. N., & Nickerson, P. W. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04013.x · Cited by 950
Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal
Lamb, K. E., Lodhi, S., & Meier-Kriesche, H.-U. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03283.x · Cited by 916
The KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Josephson, M. A. (2013) · Cited by 898
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
Dragun, D., Müller, D. N., Bräsen, J. H., Fritsche, L., Nieminen-Kelhä, M., Dechend, R., Kintscher, U., Rudolph, B., Hoebeke, J., Eckert, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa035717 · Cited by 868
Identifying Specific Causes of Kidney Allograft Loss
El-Zoghby, Z. M., Stegall, M. D., Lager, D. J., Kremers, W. K., Amer, H., Gloor, J. M., & Cosio, F. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02519.x · Cited by 801
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
Lefaucheur, C., Loupy, A., Hill, G. S., Andrade, J., Nochy, D., Antoine, C., Gautreau, C., Charron, D., Glotz, D., & Suberbielle-Boissel, C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009101065 · Cited by 789
Tait, B. D., Süsal, C., Gebel, H. M., Nickerson, P. W., Zachary, A. A., Claas, F. H. J., Reed, E. F., Bray, R. A., Campbell, P., Chapman, J. R., et al. (2013) · Transplantation · doi:10.1097/tp.0b013e31827a19cc · Cited by 787
Sis, B., Mengel, M., Haas, M., Colvin, R. B., Halloran, P. F., Racusen, L. C., Solez, K., Baldwin, W. M., Bracamonte, E. R., Broecker, V., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02987.x · Cited by 762
Larsen, C. P., Pearson, T. C., Adams, A. B., Tso, P., Shirasugi, N., Strobertb, E., Anderson, D., Cowan, S., Price, K., Naemura, J., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00749.x · Cited by 723
Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
Vo, A. A., Lukovsky, M., Toyoda, M., Wang, J., Reinsmoen, N. L., Lai, C.-H., Peng, A., Villicana, R., & Jordan, S. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707894 · Cited by 692
Desensitization in HLA-Incompatible Kidney Recipients and Survival
Montgomery, R. A., Lonze, B. E., King, K. E., Kraus, E. S., Kucirka, L. M., Locke, J. E., Warren, D. S., Simpkins, C. E., Dagher, N. N., Singer, A. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012376 · Cited by 687
Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
Einecke, G., Sis, B., Reeve, J., Mengel, M., Campbell, P. M., Hidalgo, L. G., Kaplan, B., & Halloran, P. F. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02799.x · Cited by 687
Meier-Kriesche, H.-U., Schold, J. D., & Kaplan, B. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00515.x · Cited by 607
Stegall, M. D., Diwan, T., Raghavaiah, S., Cornell, L. D., Burns, J., Dean, P. G., Cosio, F. G., Gandhi, M. J., Kremers, W., & Gloor, J. M. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03757.x · Cited by 577
Capillary deposition of C4d complement fragment and early renal graft loss
Feucht, H. E., Schneeberger, H., Hillebrand, G., Burkhardt, K., Weiss, M., Riethmüller, G., Land, W., & Albert, E. (1993) · Kidney International · doi:10.1038/ki.1993.187 · Cited by 542
COLLINS, A. B., SCHNEEBERGER, E. E., PASCUAL, M. A., SAIDMAN, S. L., WILLIAMS, W. W., TOLKOFF-RUBIN, N., COSIMI, A. B., & COLVIN, R. B. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10102208 · Cited by 515
Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure
Gaston, R. S., Cecka, J. M., Kasiske, B. L., Fieberg, A. M., Leduc, R., Cosio, F. C., Gourishankar, S., Grande, J., Halloran, P., Hunsicker, L., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e065de · Cited by 493
Self-citationSis, B., Jhangri, G. S., Bunnag, S., Allanach, K., Kaplan, B., & Halloran, P. F. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02761.x · Cited by 478
Antibodies against MICA Antigens and Kidney-Transplant Rejection
Zou, Y., Stastny, P., Süsal, C., Döhler, B., & Opelz, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067160 · Cited by 454
Kidney Paired Donation and Optimizing the Use of Live Donor Organs
Segev, D. L. (2005) · JAMA · doi:10.1001/jama.293.15.1883 · Cited by 442
Jordan, S. C., Tyan, D., Stablein, D., McIntosh, M., Rose, S., Vo, A., Toyoda, M., Davis, C., Shapiro, R., Adey, D., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145878.92906.9f · Cited by 435
Hidalgo, L. G., Sis, B., Sellares, J., Campbell, P. M., Mengel, M., Einecke, G., Chang, J., & Halloran, P. F. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03201.x · Cited by 428
Stegall, M. D., Gloor, J., Winters, J. L., Moore, S. B., & DeGoey, S. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01178.x · Cited by 428
Regele, H., Böhmig, G. A., Habicht, A., Gollowitzer, D., Schillinger, M., Rockenschaub, S., Watschinger, B., Kerjaschki, D., & Exner, M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000025780.03790.0f · Cited by 423
Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection
Mengel, M., Sis, B., Haas, M., Colvin, R. B., Halloran, P. F., Racusen, L. C., Solez, K., Cendales, L., Demetris, A. J., Drachenberg, C. B., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03926.x · Cited by 399
Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection
Everly, M. J., Everly, J. J., Susskind, B., Brailey, P., Arend, L. J., Alloway, R. R., Roy-Chaudhury, P., Govil, A., Mogilishetty, G., Rike, A. H., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e318190af83 · Cited by 392
Alemtuzumab Induction in Renal Transplantation
Hanaway, M. J., Woodle, E. S., Mulgaonkar, S., Peddi, V. R., Kaufman, D. B., First, M. R., Croy, R., & Holman, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009546 · Cited by 383
Self-citationANTI-HLA ANTIBODIES AFTER SOLID ORGAN TRANSPLANTATION1
McKenna, R. M., Takemoto, S. K., & Terasaki, P. I. (2000) · Transplantation · doi:10.1097/00007890-200002150-00001 · Cited by 382
Campath-1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study
Knechtle, S. J., Pirsch, J. D., Fechner, J. H., Becker, B. N., Friedl, A., Colvin, R. B., Lebeck, L. K., Chin, L. T., Becker, Y. T., Odorico, J. S., et al. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00120.x · Cited by 379
Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody
Gloor, J. M., Sethi, S., Stegall, M. D., Park, W. D., Moore, S. B., DeGoey, S., Griffin, M. D., Larson, T. S., & Cosio, F. G. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01895.x · Cited by 342
Locke, J. E., Magro, C. M., Singer, A. L., Segev, D. L., Haas, M., Hillel, A. T., King, K. E., Kraus, E., Lees, L. M., Melacon, J. K., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02451.x · Cited by 319
Vincenti, F., Larsen, C. P., Alberu, J., Bresnahan, B., Garcia, V. D., Kothari, J., Lang, P., Urrea, E. M., Massari, P., Mondragon-Ramirez, G., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03785.x · Cited by 313
Hidalgo, L. G., Campbell, P. M., Sis, B., Einecke, G., Mengel, M., Chang, J., Sellares, J., Reeve, J., & Halloran, P. F. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02800.x · Cited by 308
HALLORAN, P. F., WADGYMAR, A., RITCHIE, S., FALK, J., SOLEZ, K., & SRINIVASA, N. S. (1990) · Transplantation · doi:10.1097/00007890-199001000-00019 · Cited by 302
Lefaucheur, C., Nochy, D., Andrade, J., Verine, J., Gautreau, C., Charron, D., Hill, G. S., Glotz, D., & Suberbielle-Boissel, C. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02591.x · Cited by 291
Molecular Diagnosis of Antibody-Mediated Rejection in Human Kidney Transplants
Sellarés, J., Reeve, J., Loupy, A., Mengel, M., Sis, B., Skene, A., de Freitas, D. G., Kreepala, C., Hidalgo, L. G., Famulski, K. S., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12150 · Cited by 280
Donor-Specific Antibodies Adversely Affect Kidney Allograft Outcomes
Mohan, S., Palanisamy, A., Tsapepas, D., Tanriover, B., Crew, R. J., Dube, G., Ratner, L. E., Cohen, D. J., & Radhakrishnan, J. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070664 · Cited by 277
Medina Pestana, J. O., Grinyo, J. M., Vanrenterghem, Y., Becker, T., Campistol, J. M., Florman, S., Garcia, V. D., Kamar, N., Lang, P., Manfro, R. C., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03914.x · Cited by 266
Baseline Donor‐Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney Transplantation
Gloor, J. M., Winters, J. L., Cornell, L. D., Fix, L. A., DeGoey, S. R., Knauer, R. M., Cosio, F. G., Gandhi, M. J., Kremers, W., & Stegall, M. D. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02985.x · Cited by 264
Banff 2003 Meeting Report: New Diagnostic Insights and Standards
Racusen, L. C., Halloran, P. F., & Solez, K. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00585.x · Cited by 247
Liefeldt, L., Brakemeier, S., Glander, P., Waiser, J., Lachmann, N., Schönemann, C., Zukunft, B., Illigens, P., Schmidt, D., Wu, K., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03961.x · Cited by 244
Loupy, A., Hill, G. S., Suberbielle, C., Charron, D., Anglicheau, D., Zuber, J., Timsit, M. O., Duong, J. P., Bruneval, P., Vernerey, D., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03364.x · Cited by 242
Pros and cons for C4d as a biomarker
Cohen, D., Colvin, R. B., Daha, M. R., Drachenberg, C. B., Haas, M., Nickeleit, V., Salmon, J. E., Sis, B., Zhao, M.-H., Bruijn, J. A., et al. (2012) · Kidney International · doi:10.1038/ki.2011.497 · Cited by 209
Everlya, M. J., Everlya, J. J., Arend, L. J., Brailey, P., Susskind, B., Govil, A., Rike, A., Roy-Chaudhury, P., Mogilishetty, G., Allowayd, R. R., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02577.x · Cited by 208
Yabu, J. M., Higgins, J. P., Chen, G., Sequeira, F., Busque, S., & Tyan, D. B. (2011) · Transplantation · doi:10.1097/tp.0b013e318203fd26 · Cited by 202
Effect of Antibodies on Endothelium
Zhang, X., & Reed, E. F. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02819.x · Cited by 201
Daclizumab versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients
Noe[Combining Diaeresis]l, C., Abramowicz, D., Durand, D., Mourad, G., Lang, P., Kessler, M. G. A., Charpentier, B., Touchard, G., Berthoux, F. C., Merville, P., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101037 · Cited by 199
A New Diagnostic Algorithm for Antibody-Mediated Microcirculation Inflammation in Kidney Transplants
Sis, B., Jhangri, G. S., Riopel, J., Chang, J., de Freitas, D. G., Hidalgo, L., Mengel, M., Matas, A., & Halloran, P. F. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03931.x · Cited by 197
Self-citationRevisiting Traditional Risk Factors for Rejection and Graft Loss After Kidney Transplantation
Dunn, T. B., Noreen, H., Gillingham, K., Maurer, D., Ozturk, O. G., Pruett, T. L., Bray, R. A., Gebel, H. M., & Matas, A. J. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03640.x · Cited by 195
Self-citationRostaing, L., Massari, P., Garcia, V. D., Mancilla-Urrea, E., Nainan, G., Rial, M. D. C., Steinberg, S., Vincenti, F., Shi, R., Di Russo, G., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05840710 · Cited by 188
Roberts, D. M., Jiang, S. H., & Chadban, S. J. (2012) · Transplantation · doi:10.1097/tp.0b013e31825d1587 · Cited by 187
Sautenet, B., Blancho, G., Büchler, M., Morelon, E., Toupance, O., Barrou, B., Ducloux, D., Chatelet, V., Moulin, B., Freguin, C., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000000958 · Cited by 187
Freitas, M. C. S., Rebellato, L. M., Ozawa, M., Nguyen, A., Sasaki, N., Everly, M., Briley, K. P., Haisch, C. E., Bolin, P., Parker, K., et al. (2013) · Transplantation · doi:10.1097/tp.0b013e3182888db6 · Cited by 178
Summary of FDA Antibody-Mediated Rejection Workshop
Archdeacon, P., Chan, M., Neuland, C., Velidedeoglu, E., Meyer, J., Tracy, L., Cavaille-Coll, M., Bala, S., Hernandez, A., & Albrecht, R. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03525.x · Cited by 177
Otten, H. G., Verhaar, M. C., Borst, H. P. E., Hené, R. J., & Zuilen, A. D. V. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03985.x · Cited by 176
Targeting B Cells and Antibody in Transplantation
Clatworthy, M. R. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03554.x · Cited by 171
Smith, J. D., Hamour, I. M., . Banner, N. R., & Rose, M. L. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01991.x · Cited by 165
Analysis of MHC class II presentation of particulate antigens of B lymphocytes
Vidard, L., Kovacsovics-Bankowski, M., Kraeft, S. K., Chen, L. B., Benacerraf, B., & Rock, K. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.8.2809 · Cited by 151
Larsen, C. P., Knechtle, S. J., Adams, A. B., Pearson, T. C., & Kirk, A. D. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01259.x · Cited by 148
Martin, L., Guignier, F., Mousson, C., Rageot, D., Justrabo, E., & Rifle, G. (2003) · Transplantation · doi:10.1097/01.tp.0000078895.24606.45 · Cited by 136
Impact of rituximab therapy for treatment of acute humoral rejection
Kaposztas, Z., Podder, H., Mauiyyedi, S., Illoh, O., Kerman, R. H., Reyes, M. T., Pollard, V., & Kahan, B. D. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2008.00902.x · Cited by 131
Heidt, S., Hester, J., Shankar, S., Friend, P. J., & Wood, K. J. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04012.x · Cited by 130
Waiser, J., Budde, K., Schutz, M., Liefeldt, L., Rudolph, B. D., Schönemann, C., Neumayer, H.-H., & Lachmann, N. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr465 · Cited by 127
Antibody-Mediated Rejection in Kidney Transplantation: A Review
Puttarajappa, C. M., Shapiro, R., & Tan, H. P. (2012) · Journal of Transplantation · doi:10.1155/2012/193724 · Cited by 126
Post-Transplant Anti-HLA Class II Antibodies as Risk Factor for Late Kidney Allograft Failure
Campos, É. F., Junior, H. T. S., Machado, P. G. P., Franco, M. S., Pestana, J. O. M., & Gerbase‐DeLima, M. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01503.x · Cited by 124
MicroRNA Sequence Profiles of Human Kidney Allografts With or Without Tubulointerstitial Fibrosis
Ben‐Dov, I. Z., Muthukumar, T., Morozov, P. S., Mueller, F. B., Tuschl, T., & Suthanthiran, M. (2012) · Transplantation · doi:10.1097/tp.0b013e3182751efd · Cited by 122
Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab
Vo, A. A., Petrozzino, J. J., Yeung, K., Sinha, A. P., Kahwaji, J. M., Peng, A., Villicana, R., Mackowiak, J. I., & Jordan, S. C. (2013) · Transplantation · doi:10.1097/tp.0b013e3182802f88 · Cited by 116
Alemtuzumab Induction Therapy in Kidney Transplantation
Morgan, R. D., O'Callaghan, J. M., Knight, S. R., & Morris, P. J. (2012) · Transplantation · doi:10.1097/tp.0b013e318257ad41 · Cited by 104
Current approaches to treatment of antibody‐mediated rejection
Jordan, S. C., Vo, A. A., Tyan, D. B., Nast, C. C., & Toyoda, M. (2005) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2005.00363.x · Cited by 99
Medical Care of Kidney Transplant Recipients after the First Posttransplant Year
Djamali, A., Samaniego, M., Muth, B. L., Muehrer, R. J., Hofmann, R. M., Pirsch, J. D., Howard, A., Mourad, G., & Becker, B. N. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01371005 · Cited by 99
Self-citationAn Integrated View of Molecular Changes, Histopathology and Outcomes in Kidney Transplants
Halloran, P. F., de Freitas, D. G., Einecke, G., Famulski, K. S., Hidalgo, L. G., Mengel, M., REEVE, J. P., Sellarés, J., & Sis, B. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03268.x · Cited by 94
BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab
Bloom, D. D., Chang, Z., Pauly, K., Kwun, J., Fechner, J. H., Hayes, C. E., Samaniego, M., & Knechtle, S. J. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02710.x · Cited by 94
Self-citationNatural killer cells in rejection and tolerance of solid organ allografts
Benichou, G., Yamada, Y., Aoyama, A., & Madsen, J. (2011) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32834254cf · Cited by 92
Thibaudin, D., Alamartine, É., de Filippis, J. P., Diab, N., Laurent, B., & Berthoux, F. C. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.3.711 · Cited by 84
Todeschini, M., Cortinovis, M., Perico, N., Poli, F., Innocente, A., Cavinato, R. A., Gotti, E., Ruggenenti, P. L., Gaspari, F., Noris, M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203261 · Cited by 82
Rituximab in renal transplantation
Barnett, N., Hadjianastassiou, V. G., & Mamode, N. (2013) · Transplant International · doi:10.1111/tri.12072 · Cited by 80
Marfo, K., Ling, M., Bao, Y., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e3182590d2e · Cited by 76
Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale
Fehr, T. H., & Gaspert, A. (2012) · Transplant International · doi:10.1111/j.1432-2277.2012.01453.x · Cited by 76
Singh, N. K., Djamali, A., Lorentzen, D. F., Pirsch, J. D., LEVERSON, G. E., Neidlinger, N. A., VOSS, B. J., Torrealba, J. R., Hofmann, R. M., Odorico, J. S., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181f6a07b · Cited by 74
Self-citationReversing Endogenous Alloreactive B Cell GC Responses With Anti-CD154 or CTLA-4Ig
Chen, J., Yin, H., Xu, J., Wang, Q., Edelblum, K. L., Sciammas, R., & Chong, A. S. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12350 · Cited by 73
Cryptic B Cell Response to Renal Transplantation
Lynch, R., Silva, I. A., Chen, B. J., Punch, J. D., Cascalho, M., & Platt, J. L. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12308 · Cited by 73
Antibody-mediated rejection in kidney transplantation: an update
Lucas, J. G., Co, J. P., Nwaogwugwu, U., Dosani, I., & Sureshkumar, K. K. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.525219 · Cited by 73
Knechtle, S. J., Pascual, J., Bloom, D. D., Torrealba, J. R., Jankowska−Gan, E., Burlingham, W. J., Kwun, J., Colvin, R. B., Seyfert‐Margolis, V., Bourcier, K., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02581.x · Cited by 67
Drachenberg, C. B., & Papadimitriou, J. C. (2013) · Transplantation · doi:10.1097/tp.0b013e31827e6b45 · Cited by 65
Kedainis, R., Koch, M. J., Brennan, D. C., & Liapis, H. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02555.x · Cited by 54
Willicombe, M. K., Roufosse, C. A., Brookes, P., Galliford, J. W., Mclean, A. G., Dorling, A., Warrens, A. Ν., Cook, T. H., Cairns, T. D. H., & Taube, D. H. (2011) · Transplantation · doi:10.1097/tp.0b013e318222c9c6 · Cited by 51
Antibody-Mediated Rejection: Pathogenesis, Prevention, Treatment, and Outcomes
Blume, O. R., Yost, S. E., & Kaplan, B. E. (2012) · Journal of Transplantation · doi:10.1155/2012/201754 · Cited by 50
Leptin Modulates Allograft Survival by Favoring a Th2 and a Regulatory Immune Profile
Moraes‐Vieira, P. M., Bassi, Ê. J., Larocca, R. A., Castoldi, Â., Burghos, M., Lepique, A. P., Quintana, F. J., Araújo, R. C., Basso, A. S., Strom, T. B., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04283.x · Cited by 41
Bortezomib: a new player in pre- and post-transplant desensitization?
Lemy, A., Toungouz, M., & Abramowicz, D. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq502 · Cited by 37
New approaches for detecting complement-fixing antibodies
Tyan, D. B. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328355fb9b · Cited by 30
Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü, T.-M., Yang, S., Wu, W., & Tan, M. J. (2011) · PubMed · Cited by 26
Prevention of antibody-mediated kidney transplant rejection
Morath, C. P., Opelz, G., Zeier, M. G., & Süsal, C. (2012) · Transplant International · doi:10.1111/j.1432-2277.2012.01490.x · Cited by 26
Improved generation of HLA class I/peptide tetramers
Sato, Y., Sahara, H., Tsukahara, T., Kondo, M., Hirohashi, Y., Nabeta, Y., Kawaguchi, S., Ikeda, H., Torigoe, T., Ichimiya, S., et al. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00329-0 · Cited by 20
(2011) · PubMed · Cited by 10
Cited by
Demetris, A. J., Bellamy, C., Hübscher, S. G., O’Leary, J., Randhawa, P. S., Feng, S., Neil, D., Colvin, R. B., McCaughan, G., Fung, J. J., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13909 · Cited by 650
Cell-Free DNA and Active Rejection in Kidney Allografts
Bloom, R. D., Bromberg, J. S., Poggio, E. D., Bunnapradist, S., Langone, A. J., Sood, P., Matas, A. J., Mehta, S., Mannon, R. B., Sharfuddin, A., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016091034 · Cited by 584
Self-citationGeneration of hypoimmunogenic human pluripotent stem cells
Han, X., Wang, M., Duan, S., Franco, P. J., Kenty, J. H.-R., Hedrick, P., Xia, Y., Allen, A., Ferreira, L. M. R., Strominger, J. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902566116 · Cited by 363
Choi, J., Aubert, O., Vo, A., Loupy, A., Haas, M., Puliyanda, D., Kim, I., Louie, S., Kang, A., Peng, A., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14228 · Cited by 355
Donor-Specific Antibodies in Kidney Transplant Recipients
Zhang, R. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00700117 · Cited by 290
Metadata
- Authors
- Djamali, A., Kaufman, D. B., Ellis, T. M., Zhong, W., Matas, A., & Samaniego, M.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 14
- Issue
- 2
- Pages
- 255-271
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W1526559676
- Cited by
- 369
- References
- 101
- FWCI
- 39.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.